GNRH-AGONIST CO-TREATMENT DURING CHEMOTHERAPY FOR THE PRESERVATION OF OVARIAN FUNCTION: A META-ANALYSIS.

被引：1
|
作者：
Gharwan, H. [1 ]
Wilkerson, J. [1 ]
Fojo, A. T. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
FERTILITY AND STERILITY | 2014年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2014.07.544
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-59
引用
收藏
页码：E159 / E159
页数：1
相关论文
共 50 条
  • [31] THE NEW STANDARD FOR OVULATION TRIGGERING SHOULD BE GNRH AGONIST OVER HCG DURING CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Bourdon, Mathilde
    Peigne, Maeliss
    Solignac, Celine
    Darne, Bernadette M.
    Languille, Solene
    Pocate-Cheriet, Khaled
    Santulli, Pietro
    FERTILITY AND STERILITY, 2020, 114 (03) : E163 - E164
  • [32] GnRH-agonist implants suppress reproductive function and affects ovarian LHR and FSHR expression in prepubertal female cats
    Mehl, N. S.
    Srisuwatanasagul, S.
    Swangchan-Uthai, T.
    Sirivaidyapong, S.
    Khalid, M.
    THERIOGENOLOGY, 2017, 87 : 250 - 258
  • [33] The use of GnRH analogs in preserving ovarian function during chemotherapy
    Omar M. Odeh
    Johnny Awwad
    Dalia Khalife
    Suleiman Ghunaim
    Middle East Fertility Society Journal, 26
  • [34] The use of GnRH analogs in preserving ovarian function during chemotherapy
    Odeh, Omar M.
    Awwad, Johnny
    Khalife, Dalia
    Ghunaim, Suleiman
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2021, 26 (01)
  • [35] Ovarian function preservation in patients under chemotherapy treatment
    Tempone, Antonio
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (09) : 481 - 482
  • [36] Severe OHSS after GnRH-agonist triggering is not eliminated if hCG is co-administered at triggering and/or during the luteal phase: a systematic review and meta-analysis
    Ioannidou, P.
    Bosdou, J.
    Lainas, G.
    Lainas, T.
    Michaleli, N.
    Grimbizis, G.
    Kolibianakis, E.
    HUMAN REPRODUCTION, 2020, 35 : 1416 - 1417
  • [37] Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial
    Kucuk, Tansu
    Kozinoglu, Hakan
    Kaba, Ayten
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (04) : 123 - 127
  • [38] Analysis of the protective effect of gonadotropin releasing hormone agonist (GnRH-a) on ovarian function in premenopausal chemotherapy women with ovarian malignancies
    Cui, Haitao
    Zhu, Qianyong
    Zhao, Hongwei
    Liu, Huili
    Zhang, Yu
    JOURNAL OF ADVANCED NURSING, 2024, 80 : 83 - 83
  • [39] Is letrozole during ovarian stimulation useful in breast cancer patients undergoing fertility preservation to reduce early luteal progesterone levels following GnRH-agonist trigger?
    Lalami, Imane
    Labrosse, Julie
    Cedrin-Durnerin, Isabelle
    Comtet, Marjorie
    Vinolas, Claire
    Krief, Fabien
    Sifer, Christophe
    Peigne, Maeliss
    Grynberg, Michael
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2022, 20 (01)
  • [40] Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial
    Tansu Kucuk
    Hakan Kozinoglu
    Ayten Kaba
    Journal of Assisted Reproduction and Genetics, 2008, 25 : 123 - 127
12345